Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Chinese Atypical Hemolytic Uremic Syndrome Patients

NCT06099236 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06099236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06099236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Chinese Atypical Hemolytic Uremic Syndrome Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
January 15, 2024
Completion date
December 31, 2027
Enrollment
367 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

atypical hemolytic uremic syndrome(ahus)